Overactive Bladder Treatment Market Growth Trajectory Through 2024-2033

Spread the love

The Overactive Bladder Treatment by The Business Research Company provides market overview across 60+ geographies in the seven regions – Asia-Pacific, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa, encompassing 27 major global industries. The report presents a comprehensive analysis over a ten-year historic period (2010-2021) and extends its insights into a ten-year forecast period (2023-2033).

Learn More On The Overactive Bladder Treatment Market:

https://www.thebusinessresearchcompany.com/report/overactive-bladder-treatment-global-market-report

According to The Business Research Company’s Overactive Bladder Treatment, The overactive bladder treatment market size has grown steadily in recent years. It will grow from $3.01 billion in 2023 to $3.13 billion in 2024 at a compound annual growth rate (CAGR) of 3.8%. The growth in the historic period can be attributed to medication development, patient awareness, demographic shifts, clinical guidelines, investment in research..

The overactive bladder treatment market size is expected to see steady growth in the next few years. It will grow to $3.7 billion in 2028 at a compound annual growth rate (CAGR) of 4.3%. The growth in the forecast period can be attributed to aging population, advanced therapies, personalized medicine, healthcare investments, patient-centric care.. Major trends in the forecast period include non-pharmacological interventions, digital health solutions, alternative medicine acceptance, gender-specific approaches, holistic care..

A rising geriatric population is expected to boost the growth of the overactive bladder treatment market going forward. The geriatric population refers to the population of people aged 65 and older. Geriatric patients are more vulnerable to urinary tract infections due to a variety of factors, such as decreased urine flow, an overactive bladder, an enlarged prostate, or kidney stones. This will propel demand for overactive bladder treatments. For instance, in July 2022, according to the ReliefWeb, a US-based humanitarian information portal, the global population of people aged 65 or older is expected to increase from 10% in 2022 to 16% in 2050. Further, this population is expected to grow to 94 million by 2050, accounting for 23% of the total population. Therefore, the rising geriatric population is driving the growth of the overactive bladder treatment market.

Get A Free Sample Of The Report (Includes Graphs And Tables):

https://www.thebusinessresearchcompany.com/sample.aspx?id=9950&type=smp

The overactive bladder treatment market covered in this report is segmented –

1) By Diseases Type: Idiopathic Bladder Overactivity, Neurogenic Bladder Overactivity

2) By Therapy: Anticholinergics, Mirabegron, Neurostimulation, Intravesical Instillation, Other Therapies

3) By Distribution Channel: Hospital Pharmacies, Drug Stores And Retail Pharmacies, Online Providers

Product approvals are a popular trend in the overactive bladder treatment market. Major companies operating in the market are developing advanced products integrated with the latest technologies to sustain their position in the market. For instance, in April 2023, Avation Medical Inc., a US-based advanced neuromodulation & digital health company, announced FDA clearance for The Vivally System. It is a wearable, non-invasive bladder control therapy device, and accompanying mobile application are used to treat patients suffering from urge urinary incontinence and urine urgency brought on by overactive bladder syndrome. The system combines a comfortable ankle-worn garment with an intelligent controller that delivers personalized neuromodulation energy to the tibial nerve.

The overactive bladder treatment market report table of contents includes: